Acceliant partners with leading global organizations.
Clinnex is a contract research organization (CRO) dedicated to providing comprehensive biometrics services to pharmaceutical, bio-tech, medical device companies and CROs. Clinnex’s services range from clinical data management, statistical analysis and programming, CDISC services, medical writing and consulting. Clinnex covers all phases and design of clinical research, spanning across various therapeutic areas, and delivering high quality output. At the same time, these services are tailored to fit various clinical trial needs of its clients, starting from individual stand-alone services to execution of end-to-end services as per agreed standards.
Cliantha Research, a leading life sciences company, is a global full-service contract research organization with integrated offerings in clinical, bioanalytical, dermatology, biometrics, pathology and formulation services. Cliantha acquired Karmic in 2014 to enhance its service portfolio. With this synergy, Karmic and its parent company Cliantha have strengthened their capabilities to provide end-to-end services to their global clients.
Dr. Reddy’s is an integrated pharmaceutical company, committed to providing affordable and innovative medicines for healthier lives. Through its three businesses - Pharmaceutical Services & Active Ingredients, Global Generics and Proprietary Products – Dr. Reddy’s offers a portfolio of products and services including APIs, custom pharmaceutical services, generics, biosimilars and differentiated formulations. Its major therapeutic areas of focus are gastrointestinal, cardiovascular, diabetology, oncology, pain management and dermatology. Dr. Reddy’s operates in markets across the globe. Its major markets include USA, India, Russia and CIS countries, and Europe.
Headquartered in Mumbai, India, Lupin is an innovation-led transnational pharmaceutical company producing a wide range of quality, affordable generic and branded formulations and APIs for the developed and developing markets of the world. Lupin is the fifth largest and fastest growing top 10 generics player in the US (5.6% market share by prescriptions. Source: IMS Health, September 2015) and the second largest Indian pharmaceutical company by market capitalization. The company is also the ninth largest generic pharmaceutical player in Japan and the fourth largest generic pharmaceutical company in South Africa (Source: IMS Health, March 2016).
QED Clinical Services
QED has established a purpose-built outsourcing solution to meet the specific needs of companies that are looking to outsource but need a more agile and effective global solution for the delivery of clinical trials. With access to more than 1,100 clinical experts around the world and experience in delivering nearly 1,500 trials across most therapeutic areas across its local country partner organizations, the company is able to offer a flexible delivery model that offers efficient access to real on-the-ground knowledge.